Nationwide Class Action Law Firm

  1. Home
  2.  » 
  3. Securities & Investment Fraud
  4.  » Securities Fraud Claims on Behalf of Senti Biosciences, Incorporated f/k/a Dynamics Special Purpose Corp.

Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf Senti Biosciences, Incorporated (NASDAQ: SNTI) Shareholders Who Held Dynamics Special Purpose Corp. (NASDAQ: DYNS) Shares Prior to the Merger

NEWTOWN, PA, June 26, 2023 — The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of Dynamics Special Purpose Corp. (NASDAQ: DYNS), a special purpose acquisition company (“SPAC”), who acquired DYNS shares before the closing of its business combination with Senti Biosciences, Incorporated (“Senti Bio”) (NASDAQ: SNTI), on or before June 8, 2022.

Senti Bio is a biotechnology company that is developing advanced cell and gene therapies. These therapies use gene circuits to reprogram cells with biological logic, allowing them to perceive inputs, make decisions, and respond appropriately to their cellular surroundings. Senti Bio common stock began trading on the Nasdaq Global Market under the ticker symbol “SNTI” at the opening of trading on June 9, 2022.

DYNS investors who acquired Senti Bio shares may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the merger between DYNS and Senti Bio. Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] or [email protected], or you can submit your information online HERE.

For more information, please contact:

Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected] or [email protected]

About Edelson Lechtzin LLP

Edelson Lechtzin

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Free Case Review

If you believe you were the victim of securities fraud, click “Join Investigation” below to provide us the information we need to determine your eligibility. If you qualify, someone from our firm will contact you for a free consultation regarding a potential lawsuit to recover your losses.

Join Investigation